CSL rallied +3.2% yesterday after fully digesting / embracing Wednesdays annual report i.e. NPAT came in at $US2.31bn following a 10% lift in revenue. Guidance came in a touch below analyst expectations but overall its an unquestionably strong result from a company that would rather “under promise and over deliver” – MM likes CSL after its 30% pullback and are considering adding to our original purchase around $263.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Performance update for March, stocks that drove returns & our current positioning
Close
Wednesday 24th April – ASX200 +17pts, Silver Lake (SLR), Kogan (KGN) & CPI
Close
Market Matters Research Lead Shawn Hickman with David Koch
Close
Wednesday 24th April – DOW +263pts, SPI +27pts
Close
MM remains bullish CSL
Add To Hit List
Related Q&A
What are MM’s favoured recession proof Healthcare stocks?
How would MM advocate shorting CSL?
Looking at “GARY” stocks
Question on CSL SPP
Technical view on CSL, SHL & NXT
Does MM still like CSL?
Targets for PPT, CPU & CSL
Short term price targets for various stocks
New CBA Hybrid + APX & CSL
CSL
MM’s view on CSL
Questions on CSL, REA & FMG
Relevant suggested news and content from the site
Video
WATCH
Performance update for March, stocks that drove returns & our current positioning
Recorded Tuesday 9th April
Podcast
LISTEN
Wednesday 24th April – ASX200 +17pts, Silver Lake (SLR), Kogan (KGN) & CPI
Daily Podcast Direct from the Desk
Video
WATCH
Market Matters Research Lead Shawn Hickman with David Koch
Recorded Monday 25th March
Podcast
LISTEN
Wednesday 24th April – DOW +263pts, SPI +27pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.